Filtered By:
Therapy: Corticosteroid Therapy

This page shows you your search results in order of relevance. This is page number 15.

Order by Relevance | Date

Total 6881 results found since Jan 2013.

The clinical and integrated management of COPD. An official document of AIMAR (Interdisciplinary Association for Research in Lung Disease), AIPO (Italian Association of Hospital Pulmonologists), SIMER (Italian Society of Respiratory Medicine), SIMG (Italian Society of General Medicine).
This article is being simultaneously published in Sarcoidosis Vasc Diffuse Lung Dis 2014, 31(Suppl. 1);3-21. PMID: 25057359 [PubMed]
Source: Respiratory Care - July 25, 2014 Category: Respiratory Medicine Authors: Bettoncelli G, Blasi F, Brusasco V, Centanni S, Corrado A, De Benedetto F, De Michele F, Di Maria GU, Donner CF, Falcone F, Mereu C, Nardini S, Pasqua F, Polverino M, Rossi A, Sanguinetti CM Tags: Multidiscip Respir Med Source Type: research

Complementary and alternative medicine for childhood asthma: an overview of evidence and patents.
This article overviews the evidence for the clinical efficacy of all major CAM modalities. Despite CAM modalities are extensively used by the patients with asthma, very few CAM patents are available. This article also discusses recent patents pertinent to asthma. Only a few patents on herbal medicine for asthma have been evaluated but therapeutic efficacy is not substantially documented. Parents seeking CAM for asthma must consult qualified registered practitioners before using it. PMID: 25731179 [PubMed - in process]
Source: Recent Patents on Inflammation and Allergy Drug Discovery - June 4, 2015 Category: Allergy & Immunology Tags: Recent Pat Inflamm Allergy Drug Discov Source Type: research

Sepsis: An update in management
Hospitalists are a critical link in providing evidence‐based care for patients with sepsis across the disease spectrum, from early recognition to recovery. The past decade of sepsis research has led to significant findings that will change clinical practice for hospital medicine practitioners. Although the incidence of severe sepsis in the United States has continued to rise, in‐hospital mortality has declined. Management of the spectrum of sepsis disorders is no longer restricted to the intensive care unit (ICU). This review article will provide an update in the management of sepsis for hospitalists based on recently ...
Source: Journal of Hospital Medicine - July 28, 2015 Category: Hospital Management Authors: Benjamin T. Galen, Christopher Sankey Tags: Review Source Type: research

Asthma medication prescribing before, during and after pregnancy: a study in seven European regions
Conclusions Differences were found in the prevalence of prescribing of asthma medications during and surrounding pregnancy in Europe. Inhaled β-2 agonists and inhaled corticosteroids were, however, the most popular therapeutic regimens in all databases.
Source: BMJ Open - January 19, 2016 Category: Journals (General) Authors: Charlton, R. A., Pierini, A., Klungsoyr, K., Neville, A. J., Jordan, S., de Jong-van den Berg, L. T. W., Thayer, D., Bos, H. J., Puccini, A., Hansen, A. V., Gini, R., Engeland, A., Nybo Andersen, A.-M., Dolk, H., Garne, E. Tags: Open access, Epidemiology, Respiratory medicine Research Source Type: research

Oral Corticosteroids No Benefit for LRI in Non - Asthmatic Adults
No decrease in cough duration, severity for adults without asthma with lower respiratory tract symptom
Source: Pulmonary Medicine News - Doctors Lounge - August 23, 2017 Category: Respiratory Medicine Tags: Family Medicine, Infections, Internal Medicine, Emergency Medicine, Nursing, ENT, Pharmacy, Pulmonology, Journal, Source Type: news

Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine.
Authors: Contoli M, Corsico AG, Santus P, Di Marco F, Braido F, Rogliani P, Calzetta L, Scichilone N Abstract Chronic obstructive pulmonary disease (COPD) is a major cause of mortality worldwide, whose burden is expected to increase in the next decades, because of numerous risk factors, including the aging of the population. COPD is both preventable and treatable by an effective management including risk factor reduction, prevention, assessment, and treatment of acute exacerbations and co-morbidities. The available agents approved for COPD treatment are long-acting or ultra-long-acting β2-agonists (LABAs) and long...
Source: COPD: Journal of Chronic Obstructive Pulmonary Disease - November 9, 2017 Category: Respiratory Medicine Tags: COPD Source Type: research

FDA Removes Boxed Warning From Certain Asthma Medications
Decision applies to long - acting beta agonists used in combination with inhaled corticosteroids
Source: Pulmonary Medicine News - Doctors Lounge - November 11, 2014 Category: Respiratory Medicine Tags: Family Medicine, Geriatrics, Gynecology, Internal Medicine, Allergy, Emergency Medicine, Nursing, Pediatrics, Pharmacy, Pulmonology, Institutional, Source Type: news

Adjuvant Long - Acting Muscarinic Antagonist Improves Asthma
Versus adjuvant placebo, LAMA or LABA plus inhaled corticosteroids lowers risk of asthma exacerbations
Source: Pulmonary Medicine News - Doctors Lounge - November 11, 2014 Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Pediatrics, Pharmacy, Pulmonology, Journal, Source Type: news

Mount Sinai receives NIH Grant to study use of inhaled corticosteroids for sickle cell treatment
(The Mount Sinai Hospital / Mount Sinai School of Medicine) The Departments of Emergency Medicine and Hematology at the Icahn School of Medicine at Mount Sinai have been awarded a $4 million grant from the National Institutes of Health toward further study of inhaled corticosteroids to treat sickle cell disease (SCD) in individuals who do not have asthma.
Source: EurekAlert! - Medicine and Health - August 13, 2018 Category: International Medicine & Public Health Source Type: news

Precision medicine in childhood asthma
Purpose of review Childhood asthma is a heterogeneous disease and many children have uncontrolled disease. Therefore an individualized approach is needed to improve asthma outcomes in children. Precision medicine using clinical characteristics, biomarkers, and the rapidly involving field of genomics and pharmacogenomics aims to achieve asthma control and reduce future risks with less side-effects in individual children with asthma. Recent findings It is not yet possible to select treatment options on clinical characteristics. Novel monoclonal antibodies are efficacious in patients with severe, eosinophilic asthma. Red...
Source: Current Opinion in Allergy and Clinical Immunology - February 28, 2019 Category: Allergy & Immunology Tags: PEDIATRIC ASTHMA AND DEVELOPMENT OF ATOPY: Edited by Leonard B. Bacharier and John Oppenheimer Source Type: research

Antibiotics, Corticosteroids Beneficial in COPD Exacerbations
Independent of exacerbation severity, antibiotics tied to increased resolution, less treatment failure
Source: Pulmonary Medicine News - Doctors Lounge - February 25, 2020 Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Emergency Medicine, Pharmacy, Pulmonology, Journal, Source Type: news

Guideline Issued for Nonsevere, Severe COVID - 19 Therapy
Corticosteroids recommended for severe COVID - 19 with ARDS but not severe COVID - 19 without ARDS
Source: Pulmonary Medicine News - Doctors Lounge - May 6, 2020 Category: Respiratory Medicine Tags: Family Medicine, Infections, Internal Medicine, Critical Care, Emergency Medicine, Nursing, Pathology, Pharmacy, Pulmonology, Journal, Source Type: news

Asthma Seems Not to Be Linked to COVID - 19 Hospitalization
No increased risk seen for hospitalization with ongoing use of inhaled corticosteroids
Source: Pulmonary Medicine News - Doctors Lounge - June 23, 2020 Category: Respiratory Medicine Tags: Family Medicine, Infections, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nursing, Pulmonology, Journal, Source Type: news

Oral Corticosteroid Bursts Carry Risk for Severe Adverse Events
Highest rates of adverse events seen within first month after initiating short course of oral steroids
Source: Pulmonary Medicine News - Doctors Lounge - July 7, 2020 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Family Medicine, Gastroenterology, Internal Medicine, Allergy, Emergency Medicine, Pharmacy, Pulmonology, Rheumatology, Journal, Source Type: news

COVID-19 and Headache Medicine: A Narrative Review of Non-Steroidal Anti-Inflammatory Drug (NSAID) and Corticosteroid Use.
CONCLUSION: Scientific information regarding the COVID-19 pandemic is constantly evolving, and limited or contradictory information can lead to confusion for both patients and clinicians. It is recommended that prior to prescribing non-steroidal anti-inflammatory drugs and steroids for the treatment of headache, clinicians have open discussions with their patients about the potential risks and benefits of using these medications during the COVID-19 pandemic. This manuscript summarizes the currently available evidence and understanding about these risks and benefits to help clinicians navigate such discussions. PMID: 3...
Source: Headache - July 9, 2020 Category: Neurology Authors: Arca KN, Smith JH, Chiang CC, Starling AJ, Robertson CE, Halker Singh RB, Schwedt TJ, Kissoon NR, Garza I, Rozen TD, Boes CJ, Whealy MA, VanderPluym JH Tags: Headache Source Type: research